Literature DB >> 30915639

A novel mutation in INS gene linked to permanent neonatal diabetes mellitus.

Tao Wang1, Sisi Ding2, Sicheng Li1, Heming Guo1, Xiaohong Chen1, Yun Huang1, Jian Huang3, Jianwu Wu4, Cheng Hu5, Chen Fang6, Ji Hu7.   

Abstract

PURPOSE: Neonatal diabetes mellitus (NDM) is caused by mutations in the genes responsible for pancreatic β cell mass or function. This study aimed to screen the mutations in the KCNJ11, ABCC8, and INS genes in a Chinese patient with clinical features of NDM.
METHODS: The entire coding sequence and exon/intron boundaries of KCNJ11, ABCC8, and INS genes were detected by Sanger sequencing. The pathogenicity of the mutation was determined by using online prediction programs SIFT and Mutation Taser. The conformational alterations which contribute to the change of protein function were analyzed at the structural level.
RESULTS: A novel mutation L35Q (B11) of the INS gene was discovered in the patient. As L35 residue contributes to its hydrophobic core of the protein, the L35Q substitution is predicated to affect B19-A20 disulfide bond and therefore disrupt the folding of the proinsulin, which ultimately results in beta cell apoptosis by inducing ER stress.
CONCLUSIONS: This case could help us understand the role of the INS mutation in the development of diabetes.

Entities:  

Keywords:  Diabetes related complications; INS mutation; Molecular model; Neonatal diabetes mellitus

Mesh:

Substances:

Year:  2019        PMID: 30915639     DOI: 10.1007/s12020-019-01905-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  19 in total

1.  Two unrelated patients with familial hyperproinsulinemia due to a mutation substituting histidine for arginine at position 65 in the proinsulin molecule: identification of the mutation by direct sequencing of genomic deoxyribonucleic acid amplified by polymerase chain reaction.

Authors:  F Barbetti; N Raben; T Kadowaki; A Cama; D Accili; K H Gabbay; J A Merenich; S I Taylor; J Roth
Journal:  J Clin Endocrinol Metab       Date:  1990-07       Impact factor: 5.958

2.  Diabetes caused by insulin gene (INS) deletion: clinical characteristics of homozygous and heterozygous individuals.

Authors:  Klemens Raile; Michele O'Connell; Angela Galler; George Werther; Peter Kühnen; Heiko Krude; Oliver Blankenstein
Journal:  Eur J Endocrinol       Date:  2011-05-12       Impact factor: 6.664

3.  Novel homozygous likely-pathogenic intronic variant in INS causing permanent neonatal diabetes in siblings.

Authors:  Rachel Courtney; Candace Gamble; Monica L Arango; Avni Shah; Nunilo I Rubio; Joanne Nguyen; David Rodriguez-Buritica
Journal:  J Pediatr Endocrinol Metab       Date:  2016-09-01       Impact factor: 1.634

4.  Whole-exome sequencing identifies a novel INS mutation causative of maturity-onset diabetes of the young 10.

Authors:  Jing Yan; Feng Jiang; Rong Zhang; Tongfu Xu; Zhou Zhou; Wei Ren; Danfeng Peng; Yong Liu; Cheng Hu; Weiping Jia
Journal:  J Mol Cell Biol       Date:  2017-10-01       Impact factor: 6.216

5.  Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.

Authors:  Ewan R Pearson; Isabelle Flechtner; Pål R Njølstad; Maciej T Malecki; Sarah E Flanagan; Brian Larkin; Frances M Ashcroft; Iwar Klimes; Ethel Codner; Violeta Iotova; Annabelle S Slingerland; Julian Shield; Jean-Jacques Robert; Jens J Holst; Penny M Clark; Sian Ellard; Oddmund Søvik; Michel Polak; Andrew T Hattersley
Journal:  N Engl J Med       Date:  2006-08-03       Impact factor: 91.245

Review 6.  Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.

Authors:  Siri Atma W Greeley; Rochelle N Naylor; Louis H Philipson; Graeme I Bell
Journal:  Curr Diab Rep       Date:  2011-12       Impact factor: 4.810

7.  Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis.

Authors:  Intza Garin; Emma L Edghill; Ildem Akerman; Oscar Rubio-Cabezas; Itxaso Rica; Jonathan M Locke; Miguel Angel Maestro; Adnan Alshaikh; Ruveyde Bundak; Gabriel del Castillo; Asma Deeb; Dorothee Deiss; Juan M Fernandez; Koumudi Godbole; Khalid Hussain; Michele O'Connell; Thomasz Klupa; Stanislava Kolouskova; Fauzia Mohsin; Kusiel Perlman; Zdenek Sumnik; Jose M Rial; Estibaliz Ugarte; Thiruvengadam Vasanthi; Karen Johnstone; Sarah E Flanagan; Rosa Martínez; Carlos Castaño; Ann-Marie Patch; Eduardo Fernández-Rebollo; Klemens Raile; Noel Morgan; Lorna W Harries; Luis Castaño; Sian Ellard; Jorge Ferrer; Guiomar Perez de Nanclares; Andrew T Hattersley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-28       Impact factor: 11.205

8.  Structurally abnormal insulin in a diabetic patient. Characterization of the mutant insulin A3 (Val----Leu) isolated from the pancreas.

Authors:  H Sakura; Y Iwamoto; Y Sakamoto; T Kuzuya; H Hirata
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

9.  Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.

Authors:  Emma L Edghill; Sarah E Flanagan; Ann-Marie Patch; Chris Boustred; Andrew Parrish; Beverley Shields; Maggie H Shepherd; Khalid Hussain; Ritika R Kapoor; Maciej Malecki; Michael J MacDonald; Julie Støy; Donald F Steiner; Louis H Philipson; Graeme I Bell; Andrew T Hattersley; Sian Ellard
Journal:  Diabetes       Date:  2007-12-27       Impact factor: 9.461

10.  Novel frameshift mutation in the insulin (INS) gene in a family with maturity onset diabetes of the young (MODY).

Authors:  Xiaoyu Xiao; Lili Liu; Yang Xiao; Zhiguo Xie; Long Li; Houde Zhou; Weili Tang; Shiping Liu; Zhiguang Zhou
Journal:  J Diabetes       Date:  2018-10-17       Impact factor: 4.006

View more
  1 in total

1.  Endoplasmic reticulum stress and destruction of pancreatic β cells in type 1 diabetes.

Authors:  Zhao-Hui Cao; Zhuan Wu; Cong Hu; Min Zhang; Wu-Zhou Wang; Xiao-Bo Hu
Journal:  Chin Med J (Engl)       Date:  2020-01-05       Impact factor: 2.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.